149 related articles for article (PubMed ID: 3794298)
21. Aminopyrine N-demethylation by rats with liver cirrhosis. Evidence for the intact cell hypothesis. A morphometric-functional study.
Reichen J; Arts B; Schafroth U; Zimmermann A; Zeltner B; Zysset T
Gastroenterology; 1987 Oct; 93(4):719-26. PubMed ID: 3623018
[TBL] [Abstract][Full Text] [Related]
22. Nizatidine, a new histamine H2-receptor antagonist, and hepatic oxidative drug metabolism in the rat: a comparison with structurally related compounds.
Meredith CG; Speeg KV; Schenker S
Toxicol Appl Pharmacol; 1985 Feb; 77(2):315-24. PubMed ID: 2858133
[TBL] [Abstract][Full Text] [Related]
23. Aminopyrine N-demethylation: a prognostic test of liver function in patients with alcoholic liver disease.
Schneider JF; Baker AL; Haines NW; Hatfield G; Boyer JL
Gastroenterology; 1980 Dec; 79(6):1145-50. PubMed ID: 6777231
[TBL] [Abstract][Full Text] [Related]
24. The aminopyrine breath test.
Perri F; Pastore M; Annese V; Andriulli A
Ital J Gastroenterol; 1994; 26(6):306-17. PubMed ID: 7949268
[TBL] [Abstract][Full Text] [Related]
25. Quantitative assessment of hepatic function by breath analysis after oral administration of (14C)aminopyrine.
Hepner GW; Vesell ES
Ann Intern Med; 1975 Nov; 83(5):632-8. PubMed ID: 1200495
[TBL] [Abstract][Full Text] [Related]
26. Aminopyrine disposition: studies on breath, saliva, and urine of normal subjects and patients with liver disease.
Hepner GW; Vesell ES
Clin Pharmacol Ther; 1976 Dec; 20(6):654-60. PubMed ID: 991536
[TBL] [Abstract][Full Text] [Related]
27. [Experiences with the 14C-aminopyrine breath test in liver cirrhosis and under the effect of sodium diclofenac (Voltaren)].
Reinicke C; Eitner K; Hippius M; Krombholz B; Stiller KJ; Wächter G
Dtsch Z Verdau Stoffwechselkr; 1983; 43(3):117-29. PubMed ID: 6603964
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of hepatic drug metabolism by norethindrone.
Field B; Lu C; Hepner GW
Clin Pharmacol Ther; 1979 Feb; 25(2):196-8. PubMed ID: 759072
[TBL] [Abstract][Full Text] [Related]
29. Quantitative liver function tests as surrogate markers for end-points in controlled clinical trials: a retrospective feasibility study.
Lotterer E; Högel J; Gaus W; Fleig WE; Bircher J
Hepatology; 1997 Dec; 26(6):1426-33. PubMed ID: 9397982
[TBL] [Abstract][Full Text] [Related]
30. Parameters of microsomal and cytosolic liver function but not of liver perfusion predict portal vein velocity in noncirrhotic patients with chronic hepatitis C.
Herold C; Berg P; Kupfal D; Becker D; Schuppan D; Hahn EG; Schneider HT
Dig Dis Sci; 2000 Nov; 45(11):2233-7. PubMed ID: 11215745
[TBL] [Abstract][Full Text] [Related]
31. [Foreign substances as indicators of liver function].
Preisig R
Schweiz Med Wochenschr Suppl; 1985; 19():36-42. PubMed ID: 3864235
[TBL] [Abstract][Full Text] [Related]
32. Assessment of lidocaine metabolite formation in comparison with other quantitative liver function tests.
Meyer-Wyss B; Renner E; Luo H; Scholer A
J Hepatol; 1993 Aug; 19(1):133-9. PubMed ID: 8301033
[TBL] [Abstract][Full Text] [Related]
33. Vecuronium neuromuscular blockade reflects liver function during hepatic autotransplantation in pigs.
Pittet JF; Morel DR; Mentha G; Schopfer C; Belenger J; Benakis A; Tassonyi E
Anesthesiology; 1994 Jul; 81(1):168-75. PubMed ID: 7913800
[TBL] [Abstract][Full Text] [Related]
34. Correlation between the demethylation rate of 14C-aminopyrine (breath-test) and haemodynamic parameters in congestive heart failure.
Pirotte J; El Allaf D; Carlier J
Int J Clin Pharmacol Res; 1983; 3(6):485-9. PubMed ID: 6432713
[TBL] [Abstract][Full Text] [Related]
35. [Liver function tests (galactose elimination and 14C-aminopyrine demethylation) before and after heart surgery in extracorporeal circulation].
Hempel V; Fleischmann R; Hess U; Heller W
Verh Dtsch Ges Inn Med; 1978; (84):1096-8. PubMed ID: 741890
[No Abstract] [Full Text] [Related]
36. Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function.
Wensing G; Lotterer E; Link I; Hahn EG; Fleig WE
Hepatology; 1997 Nov; 26(5):1149-55. PubMed ID: 9362355
[TBL] [Abstract][Full Text] [Related]
37. Reduced drug elimination in congestive heart failure. Studies using aminopyrine as a model drug.
Hepner GW; Vesell ES; Tantum KR
Am J Med; 1978 Aug; 65(2):371-6. PubMed ID: 686023
[TBL] [Abstract][Full Text] [Related]
38. Altered liver function in diabetes: model experiments with aminopyrine in the rat.
Zysset T; Tlach C
J Pharmacol Exp Ther; 1987 Jan; 240(1):271-6. PubMed ID: 3806388
[TBL] [Abstract][Full Text] [Related]
39. Recovery of liver function in partially hepatectomized rats evaluated by aminopyrine demethylation capacity.
Sendama I; de Hemptinne B; Lambotte L
Hepatology; 1985; 5(4):629-33. PubMed ID: 4018734
[TBL] [Abstract][Full Text] [Related]
40. [Quantitative assessment of hepatic microsomal function by breath test using 13C-aminopyrine].
Sakamoto A; Kakui S; Kawamura I; Shu S; Tokumoto N
Nihon Shokakibyo Gakkai Zasshi; 1983 Dec; 80(12):2603. PubMed ID: 6674624
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
